Th1 cells support anti-tumor responses by recruiting CD8+ T cells and activating dendritic cells, while Th2 cells can contribute to tumor progression through M2 macrophage polarization and the accumulation of myeloid-derived suppressor cells. This evidence concerns the gene CD8A and neoplasm.